These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15184835)

  • 1. Nonselective versus selective beta-blockers in the management of chronic heart failure: clinical implications of the carvedilol or Metoprolol European Trial.
    Greenberg B
    Rev Cardiovasc Med; 2004; 5 Suppl 1():S10-7. PubMed ID: 15184835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
    Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
    Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.
    Bauman JL; Talbert RL
    J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):117-28. PubMed ID: 15309248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
    Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
    Talbert RL
    Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New and old beta-blockers in the treatment of heart failure].
    Metra M; Nodari S; Bignotti T; Gnesin P; Trussardi E; Cas LD
    Recenti Prog Med; 2002 Feb; 93(2):113-24. PubMed ID: 11887345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
    Hryniewicz K; Androne AS; Hudaihed A; Katz SD
    Circulation; 2003 Aug; 108(8):971-6. PubMed ID: 12912816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker treatment of chronic heart failure: comparison of carvedilol and metoprolol.
    Maack C; Elter T; Böhm M
    Congest Heart Fail; 2003; 9(5):263-70. PubMed ID: 14564145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability of beta-blockers in heart failure: reassurance needed, reassurance provided.
    Krum H
    Ital Heart J; 2003 Apr; 4(4):225-7. PubMed ID: 12784773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta-blockers in cardiac insufficiency: should they always be considered in the therapeutic strategy? Arguments against].
    Ortigosa Aso J; Silva Melchor L; García A; de Artaza Andrade M
    Rev Esp Cardiol; 1997 May; 50(5):304-7. PubMed ID: 9281008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockade in heart failure: selective versus nonselective agents.
    Metra M; Nodari S; Dei Cas L
    Am J Cardiovasc Drugs; 2001; 1(1):3-14. PubMed ID: 14728047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Critical analysis of beta blockers in heart failure: certainty and incompleteness].
    Rapezzi C; Branzi A
    Ital Heart J Suppl; 2000 Aug; 1(8):1003-10. PubMed ID: 10993006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How should COMET influence heart failure practice?
    Adams KF
    Curr Heart Fail Rep; 2004 Jul; 1(2):67-71. PubMed ID: 16036027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do metoprolol and carvedilol have equivalent effects on diurnal heart rate in patients with chronic heart failure?
    Sanderson JE; Leung LY; Chan SK; Yip GW; Fung JW; Yu CM
    Eur J Heart Fail; 2005 Aug; 7(5):874-7. PubMed ID: 16043407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of beta-blockers in heart failure: a class specific effect?
    Di Lenarda A; Sabbadini G; Sinagra G
    Ital Heart J; 2001 May; 2(5):326-32. PubMed ID: 11392635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective or nonselective beta-adrenergic blockade in patients with congestive heart failure.
    Metra M; Nodari S; Boldi E; Dei Cas L
    Curr Cardiol Rep; 2000 May; 2(3):252-7. PubMed ID: 10980900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Arch Intern Med; 2008 Dec; 168(22):2415-21. PubMed ID: 19064823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of nonselective versus selective β-blockers on cardiac sympathetic activity and hemostasis in patients with heart failure.
    de Peuter OR; Verberne HJ; Kok WE; van den Bogaard B; Schaap MC; Nieuwland R; Meijers JC; Somsen GA; Bakx A; Kamphuisen PW
    J Nucl Med; 2013 Oct; 54(10):1733-9. PubMed ID: 23970363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Elderly heart failure patients and the role of beta-blocker therapy].
    Middeljans-Tijssen CW; Jansen RW
    Tijdschr Gerontol Geriatr; 2006 Apr; 37(2):67-77. PubMed ID: 16704019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.